Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000723629 | SCV000113368 | uncertain significance | not provided | 2013-05-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000723629 | SCV000242991 | likely benign | not provided | 2020-12-21 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23280796, 16217704, 23340081) |
Labcorp Genetics |
RCV000690814 | SCV000818542 | uncertain significance | GLUT1 deficiency syndrome 1, autosomal recessive | 2024-01-29 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 218 of the SLC2A1 protein (p.Arg218Cys). This variant is present in population databases (rs147249343, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with SLC2A1-related conditions. ClinVar contains an entry for this variant (Variation ID: 95415). Advanced modeling performed at Invitae incorporating data from internal and/or published experimental studies (Invitae) indicates that this missense variant is not expected to disrupt SLC2A1 function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |